From eggs to cells

sign that says: 'flu jab next exit'
Australia’s first cell-based influenza vaccine hits the market A new flu vaccine technology is now available to Australian pharmacies and general practices for the first time, with Seqirus announcing availability of its cell-based seasonal influenza vaccine, Flucelvax Quad. The product is a quadrivalent influenza vaccine (surface antigen, inactivated, prepared in cell cultures) for use in

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Locally produced jab now available
Next Protection paramount